ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

Califano Insists On Search Committee To Look for NCI Chief; Brown Still In Running

February 25, 1977

Clinton Endorses Legislation Preventing Genetic Discrimination

May 23, 1997

House Subcommittee Passes Bush Request for NIH, NCI Budgets.

June 9, 2006

Rauscher Mammography Guidelines Would Limit Annual Use To Members Of High Risk Group

August 13, 1976

FDA Concerned About Data-Dredging In Drug-Diagnostic Applications

January 30, 2009

Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers

May 31, 2002